KALA BIO, Inc. SEC filings KALA

KALA BIO, Inc. has 675 filings in SEC EDGAR's recent list, going back to Dec 23, 2009. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

KALA BIO, Inc. SEC filings
Form Description Filed Period
8-K Current report
Shareholder vote results
Nov 3, 2026 Nov 3, 2026
DEF 14A Proxy statement Sep 24, 2026 Nov 3, 2026
PRE 14A Preliminary proxy statement Sep 11, 2026 Sep 11, 2026
8-K Current report
Material agreement
Sep 10, 2026 Sep 3, 2026
8-K Current report
Other events
Sep 9, 2026 Sep 9, 2026
8-K Current report
Listing notice
Aug 28, 2026 Aug 27, 2026
10-Q Quarterly report Aug 19, 2026 Jun 30, 2026
NT 10-Q Filing Aug 14, 2026 Jun 30, 2026
8-K Current report
Other events
Jul 23, 2026 Jul 22, 2026
424B5 Prospectus supplement Jul 22, 2026 —
EFFECT Filing Jun 25, 2026 —
S-3/A Filing Jun 12, 2026 —
10-Q Quarterly report May 15, 2026 Mar 31, 2026
S-3 Shelf registration May 7, 2026 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
May 7, 2026 May 7, 2026
10-K Annual report Apr 15, 2026 Dec 31, 2025
NT 10-K Filing Mar 31, 2026 Dec 31, 2025
D Filing Mar 17, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Mar 4, 2026 Mar 3, 2026
8-K Current report
Officer or director change
Feb 20, 2026 Feb 16, 2026
EFFECT Filing Feb 17, 2026 —
424B3 Prospectus Feb 17, 2026 —
CORRESP Letter to the SEC Feb 13, 2026 —
UPLOAD Letter from the SEC Feb 13, 2026 —
D Filing Feb 13, 2026 —
S-3 Shelf registration Feb 10, 2026 —
8-K Current report
Officer or director change
Feb 5, 2026 Feb 2, 2026
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Feb 2, 2026 Jan 30, 2026
DEFA14A Additional proxy material Jan 26, 2026 —
8-K Current report
Listing notice
Jan 23, 2026 Jan 20, 2026
8-K Current report
Material agreement
Jan 8, 2026 Jan 8, 2026
424B5 Prospectus supplement Jan 8, 2026 —
DEFA14A Additional proxy material Jan 6, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Jan 6, 2026 Dec 30, 2025
8-K Current report
Other events
Jan 2, 2026 Dec 26, 2025
DEF 14A Proxy statement Dec 30, 2025 Jan 30, 2026
8-K Current report
Auditor change, Officer or director change
Dec 29, 2025 Dec 19, 2025
PRER14A Filing Dec 19, 2025 —
8-K Current report
Auditor change
Dec 16, 2025 Dec 15, 2025
8-K Current report
Other events
Dec 16, 2025 Dec 16, 2025
8-K Current report
Material agreement, Other events
Dec 5, 2025 Dec 4, 2025
424B5 Prospectus supplement Dec 5, 2025 —
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Officer or director change, Bylaw or fiscal year change
Nov 25, 2025 Nov 20, 2025
10-Q Quarterly report Nov 19, 2025 Sep 30, 2025
NT 10-Q Filing Nov 14, 2025 Sep 30, 2025
8-K Current report
Listing notice
Nov 12, 2025 Nov 10, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Nov 10, 2025 Nov 9, 2025
8-K Current report
Exit or restructuring costs, Officer or director change, Other events
Oct 20, 2025 Oct 19, 2025
8-K/A Amended current report
Exit or restructuring costs, Officer or director change
Oct 2, 2025 Sep 28, 2025
8-K Current report Oct 1, 2025 Sep 29, 2025
8-K Current report
Exit or restructuring costs, Other events
Sep 29, 2025 Sep 28, 2025
8-K Current report
Other events
Sep 18, 2025 Sep 16, 2025
8-K Current report
Officer or director change
Sep 2, 2025 Aug 29, 2025
10-Q Quarterly report Aug 8, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 8, 2025 Aug 8, 2025
8-K Current report
Other events
Jul 9, 2025 Jul 9, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 14, 2025 May 14, 2025
8-K Current report
Officer or director change
Apr 11, 2025 Apr 10, 2025
424B5 Prospectus supplement Mar 31, 2025 —
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
8-K Current report
Officer or director change
Feb 12, 2025 Feb 11, 2025
EFFECT Filing Feb 4, 2025 —
424B3 Prospectus Feb 4, 2025 —
CORRESP Letter to the SEC Jan 31, 2025 —
UPLOAD Letter from the SEC Jan 31, 2025 —
S-3 Shelf registration Jan 24, 2025 —
S-8 Employee stock plan registration Jan 3, 2025 —
D Filing Dec 31, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Dec 30, 2024 Dec 29, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Officer or director change
Sep 25, 2024 Sep 23, 2024
424B5 Prospectus supplement Sep 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 6, 2024 Aug 6, 2024
EFFECT Filing Jul 31, 2024 —
424B3 Prospectus Jul 31, 2024 —
CORRESP Letter to the SEC Jul 29, 2024 —
UPLOAD Letter from the SEC Jul 26, 2024 —
S-3 Shelf registration Jul 25, 2024 —
D Filing Jun 28, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Jun 27, 2024 Jun 26, 2024
8-K Current report
Shareholder vote results
Jun 12, 2024 Jun 11, 2024
DEFA14A Additional proxy material May 30, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 29, 2024 —
DEF 14A Proxy statement Apr 29, 2024 Jun 11, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Jun 11, 2024
424B5 Prospectus supplement Mar 29, 2024 —
S-8 Employee stock plan registration Mar 29, 2024 —
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 29, 2024 Mar 29, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Mar 26, 2024 Mar 25, 2024
8-K Current report
Regulation FD disclosure, Other events
Mar 4, 2024 Mar 4, 2024
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Dec 22, 2023 Dec 21, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
10-Q Quarterly report Aug 4, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 4, 2023 Aug 4, 2023
8-K Current report
Bylaw or fiscal year change
Aug 2, 2023 Aug 2, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 23, 2023 Jun 22, 2023
S-8 Employee stock plan registration Jun 22, 2023 —
DEFA14A Additional proxy material Jun 1, 2023 —
SC TO-I/A Filing May 31, 2023 —
EFFECT Filing May 11, 2023 —
DEF 14A Proxy statement May 11, 2023 Jun 22, 2023
ARS Annual report to shareholders May 11, 2023 Dec 31, 2022
SC TO-I/A Filing May 9, 2023 —
CORRESP Letter to the SEC May 9, 2023 —
S-3/A Filing May 9, 2023 —
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
SC TO-I Filing May 1, 2023 —
8-K Current report
Other events
Apr 28, 2023 Apr 28, 2023
8-K Current report
Shareholder vote results
Apr 25, 2023 Apr 24, 2023
8-K Current report
Other events
Mar 27, 2023 Mar 27, 2023
EFFECT Filing Mar 14, 2023 —
424B3 Prospectus Mar 14, 2023 —
DEF 14A Proxy statement Mar 13, 2023 Apr 24, 2023
CORRESP Letter to the SEC Mar 10, 2023 —
UPLOAD Letter from the SEC Mar 8, 2023 —
UPLOAD Letter from the SEC Mar 8, 2023 —
S-3 Shelf registration Mar 3, 2023 —
S-3 Shelf registration Mar 3, 2023 —
10-K Annual report Mar 3, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 3, 2023 Mar 3, 2023
PRE 14A Preliminary proxy statement Mar 1, 2023 Apr 24, 2023
8-K Current report
Material agreement, Other events
Jan 19, 2023 Jan 18, 2023
424B5 Prospectus supplement Jan 19, 2023 —
8-K Current report
Other events
Jan 10, 2023 Jan 9, 2023
S-8 Employee stock plan registration Jan 4, 2023 —
8-K Current report
Material agreement, New debt, Other events
Dec 27, 2022 Dec 27, 2022
8-K Current report
Listing notice
Dec 9, 2022 Dec 5, 2022
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Nov 28, 2022 Nov 28, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Officer or director change
Nov 1, 2022 Oct 31, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results, Regulation FD disclosure
Oct 20, 2022 Oct 19, 2022
DEF 14A Proxy statement Sep 9, 2022 Oct 19, 2022
PRE 14A Preliminary proxy statement Aug 30, 2022 Oct 19, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Aug 19, 2022 Aug 18, 2022
8-A12G Filing Aug 19, 2022 —
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
8-K/A Amended current report Jul 12, 2022 Jul 8, 2022
8-K Current report
Acquisition or sale of assets, Exit or restructuring costs, Listing notice, Other events
Jul 8, 2022 Jul 8, 2022
8-K Current report
Shareholder vote results
Jun 21, 2022 Jun 16, 2022
DEFA14A Additional proxy material May 31, 2022 —
8-K Current report
Listing notice
May 27, 2022 May 24, 2022
8-K Current report
Material agreement, New debt
May 23, 2022 May 21, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 16, 2022 May 16, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 16, 2022
S-8 Employee stock plan registration Mar 29, 2022 —
10-K Annual report Mar 29, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 29, 2022 Mar 29, 2022
8-K Current report
Other events
Mar 22, 2022 Mar 22, 2022
8-K Current report
Listing notice
Mar 4, 2022 Mar 2, 2022
8-K/A Amended current report Jan 28, 2022 Nov 12, 2021
8-K Current report
Officer or director change
Dec 20, 2021 Dec 16, 2021
D Filing Nov 29, 2021 —
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Results of operations, Unregistered share sale, Officer or director change
Nov 15, 2021 Nov 12, 2021
8-K Current report
Officer or director change
Oct 18, 2021 Oct 14, 2021
10-Q Quarterly report Aug 5, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 5, 2021 Aug 5, 2021
CT ORDER Filing Jul 15, 2021 —
8-K Current report
Shareholder vote results
Jun 21, 2021 Jun 17, 2021
10-Q Quarterly report May 5, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 5, 2021 May 5, 2021
8-K Current report
Material agreement, Agreement ended, New debt
May 5, 2021 May 4, 2021
DEFA14A Additional proxy material Apr 28, 2021 —
DEF 14A Proxy statement Apr 28, 2021 Jun 17, 2021
S-8 Employee stock plan registration Feb 25, 2021 —
10-K Annual report Feb 25, 2021 Dec 31, 2020
8-K Current report
Results of operations
Feb 25, 2021 Feb 25, 2021
8-K Current report
Results of operations, Other events
Jan 7, 2021 Jan 7, 2021
10-Q Quarterly report Nov 5, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 5, 2020 Nov 5, 2020
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Oct 27, 2020 Oct 27, 2020
8-K Current report
Regulation FD disclosure
Sep 17, 2020 Sep 17, 2020
10-Q Quarterly report Aug 6, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 6, 2020 Aug 6, 2020
8-K Current report
Officer or director change, Shareholder vote results
Jun 26, 2020 Jun 25, 2020
S-8 Employee stock plan registration Jun 25, 2020 —
DEFA14A Additional proxy material Jun 10, 2020 —
8-K Current report
Other events
May 26, 2020 May 26, 2020
EFFECT Filing May 19, 2020 —
CORRESP Letter to the SEC May 15, 2020 —
UPLOAD Letter from the SEC May 13, 2020 —
S-3 Shelf registration May 7, 2020 —
10-Q Quarterly report May 7, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 7, 2020 May 7, 2020
CT ORDER Filing May 1, 2020 —
DEFA14A Additional proxy material Apr 29, 2020 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KALA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Arlington, MA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1479419
Former names
KALA BIO, Inc. (until Nov 3, 2026); Kala Pharmaceuticals, Inc. (until Jun 23, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.